Skip to main content
. 2022 Feb 11;186(4):477–487. doi: 10.1530/EJE-21-1229

Table 3.

LMM development by the changes in serum 25(OH)D level from baseline to subsequent visit (n  = 131,595). P = 0.326 for the overall interaction between sex and sex and serum 25(OH)D levels for incident low muscle mass (multivariable-adjusted model 2).

25(OH)D levels (nmol/L) Person-years Incident cases Incidence density (/103 PY) Age- and sex-adjusted HR (95% CI) Multivariable-adjusted HRa (95% CI) HR (95% CI)b in a model with time-dependent variables
Visit 1 Visit 2 Model 1 Model 2
Total
 <50 <50 212,785.0 4157 19.5 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 ≥50 <50 33,319.2 556 16.7 0.85 (0.78–0.93) 0.85 (0.78–0.93) 0.84 (0.77–0.92) 0.86 (0.78–0.94)
 <50 ≥50 63,741.6 1001 15.7 0.80 (0.75–0.86) 0.85 (0.80–0.92) 0.85 (0.79–0.91) 0.87 (0.81–0.93)
 ≥50 ≥50 60,559.7 956 15.8 0.79 (0.74–0.85) 0.81 (0.75–0.87) 0.81 (0.75–0.87) 0.84 (0.78–0.90)
Women
 <50 <50 101,903.1 2262 22.2 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 ≥50 <50 10,964.2 201 18.3 0.83 (0.72–0.95) 0.81 (0.70–0.93) 0.88 (0.76–1.02) 0.87 (0.75–1.01)
 <50 ≥50 25,365.8 410 16.2 0.73 (0.66–0.81) 0.76 (0.69–0.85) 0.80 (0.72–0.89) 0.84 (0.75–0.93)
 ≥50 ≥50 15,201.1 257 16.9 0.75 (0.66–0.85) 0.75 (0.66–0.86) 0.83 (0.72–0.94) 0.89 (0.78–1.01)
Men
 <50 <50 110,881.9 1895 17.1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
 ≥50 <50 22,355.0 355 15.9 0.93 (0.83–1.04) 0.84 (0.75–0.94) 0.83 (0.74–0.93) 0.85 (0.76–0.95)
 <50 ≥50 38,375.8 591 15.4 0.90 (0.82–0.99) 0.93 (0.85–1.03) 0.90 (0.82–0.98) 0.89 (0.81–0.97)
 ≥50 ≥50 45,358.6 699 15.4 0.88 (0.81–0.97) 0.82 (0.75–0.90) 0.80 (0.74–0.88) 0.82 (0.76–0.90)

aEstimated using Cox proportional hazard models. The multivariable model 1 was adjusted for age, sex, centre, year of screening examination, alcohol consumption, smoking, physical activity, total energy intake, education level, and BMI; model 2: model 1 plus adjustment for medication for hyperlipidaemia, medication for diabetes, multivitamin supplement, vitamin D supplement, and calcium supplement. bEstimated using Cox proportional hazard models with categories of serum 25(OH)D levels, smoking, alcohol consumption, physical activity, total energy intake, BMI, medication for hyperlipidaemia, medication for hyperlipidaemia, medication for diabetes, multivitamin supplement, vitamin D supplement, and calcium supplement as time-dependent variables and baseline age, centre, year of screening examination, and education level as time-fixed variables.

HR, hazards ratio; LMM, low muscle mass; PY, person-years.